Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer-Reference-Cited by-同舟云学术

Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer

Published:2023-01 Issue: Volume:180 Page:106331
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Zhong Ming,Chalbatani Ghanbar Mahmoodi,Deng Meifang,Li Qiuyi,Gharagouzloo Elahe,Hamblin Michael R,Suarez Eloah Rabello,Hu Lili,Wang Dingding

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. I-TASSER: a unified platform for automated protein structure and function prediction;Ambrish;Nat. Protoc.,2010

2. Chimeric antigen receptor-modified T cells for the treatment of solid tumors: defining the challenges and next steps;Beatty;Pharmacol. Ther.,2016

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

4. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumors and blood;Bremnes;Lung Cancer,2006

5. Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice;Chinnasamy;Cancer Res.,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17

2. Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives;OncoTargets and Therapy;2023-07